GAITHERSBURG, Md.--Oncormed here has received a US patent on a full-length coding sequence of the BRCA1 gene that encodes the entire BRCA1 protein. The company's rights in the patented sequence include therapeutics and diagnostic products and services. The company also recently received a worldwide exclusive license to the BRCA2 gene for diagnostic purposes.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.